M&A · Healthcare · Biological Products, (No Diagnostic Substances)
Concentra Biosciences, LLC to acquire Jounce Therapeutics, Inc.
Announced Mar 27, 2023 · Closed May 4, 2023
Deal value$96M
Premium75.0%To unaffected price
EV / Adj. EBITDA—
ConsiderationAll cash$1.85 per share
Transaction
- Acquirer
- Concentra Biosciences, LLC
- Target
- Jounce Therapeutics, Inc.
- Buyer type
- Private equity
- Offer price per share
- $1.85
- Enterprise value
- —
- Status
- Closed May 4, 2023
Deal protections
- Break fee (target pays)
- $4.0M · 4.1%
- Reverse fee (buyer pays)
- —
- Go-shop
- —
- Financing
- No financing condition
Advisors
- To the acquirer
- Not disclosed
- To the target
- TD Cowen
Sector context · Healthcare
- Comparable deals
- 76 in the prior 24 months
- Premium
- 75.0% vs. 47.3% sector median
- EV / Adj. EBITDA
- Sector median 21.1x
- Break fee
- 4.1% vs. 3.5% sector median
Timeline
- AnnouncedMar 27, 2023
- Tender offerMar 27, 2023
- ClosedMay 4, 2023